Terms: = Liver cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
48 results:
1. Ginsenoside compound K induces ferroptosis via the FOXO pathway in liver cancer cells.
Chen J; Wang Z; Fu J; Cai Y; Cheng H; Cui X; Sun M; Liu M; Zhang X
BMC Complement Med Ther; 2024 Apr; 24(1):174. PubMed ID: 38664638
[TBL] [Abstract] [Full Text] [Related]
2. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
3. Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways.
Yu CL; Lai YW; Chen JJ; Lee JJ; Chou TH; Huang CC; Liu SC; Chen GW; Tsai CH; Wang SW
J Food Drug Anal; 2023 Dec; 31(4):696-710. PubMed ID: 38526828
[TBL] [Abstract] [Full Text] [Related]
4. Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model.
Curran CS; Cui X; Li Y; Jeakle M; Sun J; Demirkale CY; Minkove S; Hoffmann V; Dhamapurkar R; Chumbris S; Bolyard C; Iheanacho A; Eichacker PQ; Torabi-Parizi P
Front Immunol; 2023; 14():1308358. PubMed ID: 38259435
[TBL] [Abstract] [Full Text] [Related]
5. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
[TBL] [Abstract] [Full Text] [Related]
6. Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer.
Jiang B; Cui Y; Ma X; Zhang Y; Feng X; Yang T; Feng L; Guo W; Li Y; Wang T; Guo H; Li H; Duan Y; Su H
Int Immunopharmacol; 2023 Nov; 124(Pt B):111040. PubMed ID: 37839277
[TBL] [Abstract] [Full Text] [Related]
7. Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin.
Liu J; Zhang Q; Wang C; Yang J; Yang S; Wang T; Wang B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108785
[TBL] [Abstract] [Full Text] [Related]
8. TRIM15 forms a regulatory loop with the AKT/foxo1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs.
Yang C; Jin X; Liu X; Wu G; Yang W; Pang B; Jiang J; Liao D; Zhang Y
Cell Death Dis; 2023 Jan; 14(1):47. PubMed ID: 36670097
[TBL] [Abstract] [Full Text] [Related]
9. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/foxo1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacological and Therapeutic Applications of Esculetin.
Garg SS; Gupta J; Sahu D; Liu CJ
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293500
[TBL] [Abstract] [Full Text] [Related]
11. Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats.
Sun S; Liu L; Song H; Li H
Pharm Biol; 2022 Dec; 60(1):1944-1948. PubMed ID: 36226863
[TBL] [Abstract] [Full Text] [Related]
12. Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma.
Wang C; Liang H; Li Y; Tang Z; Zhang Y
Bioengineered; 2022 May; 13(5):12738-12748. PubMed ID: 35609322
[TBL] [Abstract] [Full Text] [Related]
13. Deacetylated-poly-N-acetylglucosamine-folic Acid as a Nanocarrier for Delivering miR-196a Inhibitor to Anticancer Activity.
Hao Y; Li X
Balkan Med J; 2022 Jan; 39(1):55-65. PubMed ID: 35330543
[TBL] [Abstract] [Full Text] [Related]
14. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
[TBL] [Abstract] [Full Text] [Related]
15. The Mutual Inhibition of foxo1 and SREBP-1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism.
Hu Y; Zai H; Jiang W; Ou Z; Yao Y; Zhu Q
Mediators Inflamm; 2021; 2021():5754592. PubMed ID: 34539243
[TBL] [Abstract] [Full Text] [Related]
16. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/foxo1/p27
Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
[TBL] [Abstract] [Full Text] [Related]
17. PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Jiang TY; Pan YF; Wan ZH; Lin YK; Zhu B; Yuan ZG; Ma YH; Shi YY; Zeng TM; Dong LW; Tan YX; Wang HY
Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32967970
[TBL] [Abstract] [Full Text] [Related]
18. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
[TBL] [Abstract] [Full Text] [Related]
19. Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway.
Zhang Y; Li C; Li X; Wu C; Zhou H; Lu S; Liu X
Mol Med Rep; 2020 Sep; 22(3):2174-2182. PubMed ID: 32705195
[TBL] [Abstract] [Full Text] [Related]
20. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
[TBL] [Abstract] [Full Text] [Related]
[Next]
